Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. 2008

John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
Department of Biomedical Sciences, Marquette University, Schroeder Health Complex, P.O. Box 1881, Milwaukee, WI 53201-1881, USA. john.mantsch@marquette.edu

BACKGROUND Stressful events during periods of drug abstinence likely contribute to relapse in cocaine-dependent individuals. Excessive cocaine use may increase susceptibility to stressor-induced relapse through alterations in brain corticotropin-releasing factor (CRF) responsiveness. OBJECTIVE This study examined stressor- and CRF-induced cocaine seeking and other stress-related behaviors in rats with different histories of cocaine self-administration (SA). METHODS Rats self-administered cocaine under short-access (ShA; 2 h daily) or long-access (LgA; 6 h daily) conditions for 14 days or were provided access to saline and were tested for reinstatement by a stressor (electric footshock), cocaine or an icv injection of CRF and for behavioral responsiveness on the elevated plus maze, in a novel environment and in the light-dark box after a 14- to 17-day extinction/withdrawal period. RESULTS LgA rats showed escalating patterns of cocaine SA and were more susceptible to reinstatement by cocaine, EFS, or icv CRF than ShA rats. Overall, cocaine SA increased activity in the center field of a novel environment, on the open arms of the elevated plus maze, and in the light compartment of a light-dark box. In most cases, the effects of cocaine SA were dependent on the pattern/amount of cocaine intake with statistically significant differences from saline self-administering controls only observed in LgA rats. CONCLUSIONS When examined after several weeks of extinction/withdrawal, cocaine SA promotes a more active pattern of behavior during times of stress that is associated with a heightened susceptibility to stressor-induced cocaine-seeking behavior and may be the consequence of augmented CRF regulation of addiction-related neurocircuitry.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions
D005239 Fear The affective response to an actual current external danger which subsides with the elimination of the threatening condition. Threat Cues,Threat Sensitivity,Cue, Threat,Fears,Sensitivity, Threat,Threat Cue,Threat Sensitivities
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D001143 Arousal Cortical vigilance or readiness of tone, presumed to be in response to sensory stimulation via the reticular activating system. Vigilance, Cortical,Arousals,Cortical Vigilance
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations

Related Publications

John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
March 2012, Addiction biology,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
September 2010, Neuroscience,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
December 1988, Gastroenterology,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
November 2012, Pharmacology, biochemistry, and behavior,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
April 2009, Addiction biology,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
March 2006, General and comparative endocrinology,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
August 2020, British journal of pharmacology,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
January 1992, Brain research,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
September 2007, The Journal of pharmacology and experimental therapeutics,
John R Mantsch, and David A Baker, and David M Francis, and Eric S Katz, and Michael A Hoks, and Joseph P Serge
August 2018, Drug and alcohol dependence,
Copied contents to your clipboard!